MAGEA3 and Miyoshi myopathy: The results of this study strongly suggested that MAGE-C1/CT7, MAGE-A3 and MAGE-C2/CT10 expression levels could act as clinical indicators for the auxiliary diagnosis and monitoring of treatment efficacy in MM.